{"id":"https://openalex.org/W2355036675","doi":null,"title":"The Effect of Salmeterol Xinafoate and Fluticasone Propionate Powder for in Treating Chronic Obstructive Pulmonary Disease","display_name":"The Effect of Salmeterol Xinafoate and Fluticasone Propionate Powder for in Treating Chronic Obstructive Pulmonary Disease","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2355036675","mag":"2355036675"},"language":"en","primary_location":{"id":"mag:2355036675","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-HZYZ200904008.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764494613","display_name":"Journal of Heze Medical College","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Heze Medical College","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100867726","display_name":"Yang Jun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yang Jun","raw_affiliation_strings":["The Yuanlin Hosptital of Qianjiang City,Qianjiang 433100,Hubei)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Yuanlin Hosptital of Qianjiang City,Qianjiang 433100,Hubei)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5100867726"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36782361,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.972000002861023},{"id":"https://openalex.org/keywords/salmeterol-xinafoate","display_name":"salmeterol xinafoate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/fluticasone-propionate","display_name":"fluticasone propionate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-inhaler-therapy","display_name":"combination inhaler therapy","score":0.718999981880188},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.9750000238418579},{"id":"https://openalex.org/keywords/arterial-oxygenation","display_name":"arterial oxygenation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/pao2","display_name":"PaO2","score":0.6639999747276306},{"id":"https://openalex.org/keywords/paco2","display_name":"PaCO2","score":0.9829999804496765},{"id":"https://openalex.org/keywords/symptom-recovery","display_name":"symptom recovery","score":0.6299999952316284},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.828000009059906}],"concepts":[{"id":"https://openalex.org/C2779028295","wikidata":"https://www.wikidata.org/wiki/Q8564098","display_name":"Fluticasone propionate","level":3,"score":0.9606961607933044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9341311454772949},{"id":"https://openalex.org/C2776719499","wikidata":"https://www.wikidata.org/wiki/Q424333","display_name":"Salmeterol","level":3,"score":0.8159115314483643},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.7344090342521667},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.7017000913619995},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.5850793719291687},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4612971246242523},{"id":"https://openalex.org/C2781212218","wikidata":"https://www.wikidata.org/wiki/Q1002165","display_name":"Fluticasone","level":3,"score":0.4257444441318512},{"id":"https://openalex.org/C75603125","wikidata":"https://www.wikidata.org/wiki/Q1877462","display_name":"Pulmonary function testing","level":2,"score":0.4147043824195862},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3738202452659607}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2355036675","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-HZYZ200904008.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764494613","display_name":"Journal of Heze Medical College","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Heze Medical College","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2357273874","https://openalex.org/W2366660330","https://openalex.org/W2353581229","https://openalex.org/W2353186812","https://openalex.org/W2362987103","https://openalex.org/W2382807022","https://openalex.org/W2384273227","https://openalex.org/W2354039397","https://openalex.org/W2385617483","https://openalex.org/W3030531948"],"abstract_inverted_index":{"Objective":[0],"To":[1],"study":[2,39],"the":[3,38,58,82,105,117,125,136,161],"effect":[4],"of":[5,41,78,81,93,111,113,119,124,128,135,148,155,163],"Salmeterol":[6,66,175],"Xinafoate":[7,67,176],"and":[8,49,68,144,170,177,186],"Fluticasone":[9,178],"Propionate":[10,70,179],"Powder":[11,71,180],"for":[12,72,142,181,189],"Inhalation":[13,73,182],"on":[14],"chronic":[15],"obstructive":[16],"pulmonary":[17],"disease.Methods":[18],"The":[19,139],"patients":[20,52,59,83,165],"with":[21,55,65],"COPD":[22,190],"who":[23],"were":[24,35,43,53,63,99,131],"treated":[25,54,64],"in":[26,60,84,96,104],"our":[27],"hospital":[28],"during":[29],"January":[30],"2007":[31],"to":[32],"December":[33],"2008":[34],"selected":[36],"as":[37],"objects.All":[40],"them":[42],"divided":[44],"into":[45],"2":[46],"groups:trial":[47],"group":[48,62,98,130,150],"control":[50,106,137,156],"group.All":[51],"conventional":[56],"therapy,and":[57],"treatment":[61,97,129],"Futicasone":[69],"additionly.Results":[74],"1)":[75],"Every":[76],"parameter":[77,95],"lung":[79],"function":[80],"both":[85,114],"groups":[86,115],"increased":[87],"after":[88],"treated(P0.":[89],"05).The":[90],"value":[91,122],"changes":[92,123],"every":[94],"significantly":[100],"higher":[101,132,152],"than":[102,133,153],"those":[103,134],"group(P0.05).2)":[107],"After":[108],"treated,the":[109],"level":[110,118],"PaO_2":[112],"increased,while":[116],"PaCO_2":[120],"decreased.Than":[121],"two":[126],"parameters":[127],"group.3)":[138],"efficient":[140],"rate":[141],"symptom":[143],"body":[145],"sign":[146],"recovery":[147],"trial":[149],"was":[151,183],"that":[154],"group.(trial":[157],"group:66%;control":[158],"group:62%;P0.05).4)":[159],"During":[160],"period":[162],"treatment,three":[164],"manifested":[166],"adverse":[167],"drug":[168,188],"reaction":[169],"recovered":[171],"without":[172],"any":[173],"therapy.Conclusions":[174],"a":[184],"safe":[185],"effective":[187],"patients.":[191]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}